Latest News
View all stories
ScienceMedPage Endocrinology
Obesity Drug Trial Participants Abandon Studies After Identifying Placebo Treatment
Patients in obesity drug trials frequently recognize placebo treatments and withdraw from studies to seek effective GLP-1 medications, creating challenges for clinical trial validity.
LifestyleSelf
GLP-1 Medications Drive Gym Members from Cardio to Weight Training
ScienceMedPage Endocrinology
GLP-1 Drugs Cut Death Risk 28% in Diabetic Cancer Patients with Brain Metastases
RegulatoryEndpoints News
FDA Approves Novo Nordisk's Awiqli as First Weekly Insulin for Type 2 Diabetes
LifestyleMen's Health
Food Companies Market 'GLP-1 Friendly' Labels Without FDA Standards
ScienceSelf
GLP-1 Medications Reduce Depression Risk by 20% Independent of Weight Loss
治療の全行程ガイド
適切な薬の選択から長期的な成果の維持まで、あらゆる段階での包括的で独立したガイダンス。
治療前
薬データベースと意思決定エンジン
Ozempic、Wegovy、Zepbound、Mounjaro — 臨床効果データ、投与スケジュール、保険適用の並列比較。
Explore the Drug Database